Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04182672 · ClinicalTrials.gov registry record · Phase 2
Study to Assess the Safety and Efficacy of FX006 Administered to Patients With Greater Trochanteric Bursitis
A Phase 2 study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- Phase 2
- Development phase
- 22
- Enrollment target
NCT04182672 is a Phase 2 study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 22 participants.
The verdict
NCT04182672, a Phase 2 study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 22 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the safety and efficacy of FX006 in bursal injections and to assess the patient's impression to change in their chronic pain, following treatment.
Interventions
- DRUG FX006
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2020-08-12 |
| Est. Completion | 2022-12-14 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04182672
The ClinicalTrials.gov registry entry for NCT04182672 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which FX006 is the first listed.
NCT04182672 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04182672 about?
NCT04182672 is a clinical study titled "Study to Assess the Safety and Efficacy of FX006 Administered to Patients With Greater Trochanteric Bursitis". The purpose of this study is to determine the safety and efficacy of FX006 in bursal injections and to assess the patient's impression to change in their chronic pain, following treatment.
What is the current status of trial NCT04182672?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 22 participants. The study started on 2020-08-12. Estimated completion is 2022-12-14.
What interventions are being tested in trial NCT04182672?
The interventions under investigation include: FX006 (DRUG).
Who is sponsoring clinical trial NCT04182672?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.